BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, October 30, 2024
Breaking News: Best of BioWorld Science: Q3
See today's BioWorld Science
Home
» TYK Medicines reports new compounds for preventing and/or treating neurodegenerative disease
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Neurology/psychiatric
TYK Medicines reports new compounds for preventing and/or treating neurodegenerative disease
Aug. 1, 2024
No Comments
TYK Medicines Inc. has patented compounds reported to be useful for the treatment of Alzheimer’s, Parkinson’s and Huntington diseases as well as amyotrophic lateral sclerosis, epilepsy and spinocerebellar ataxia.
BioWorld Science
Neurology/psychiatric
Patents